<unk>  is an antidiabetic that is FDA approved for the treatment of patients with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose] control despite optimal insulin therapy. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include abdominal pain, anorexia, nausea, vomiting, hypersensitivity reaction, dizziness, headache.
Pramlintide
Rotigaptide
Linaclotide
Insulin glulisine
Insulin degludec
Glyburide
Insulin detemir
Insulin aspart